# WHO lists Sinopharm’s COVID-19 vaccine for emergency use

Date: 2021

## The fact

On 7 May 2021 the World Health Organization listed Sinopharm’s BBIBP-CorV COVID-19 vaccine for emergency use. Xi did not sit as the SAGE panel.

## Context

NMPA had authorised in December 2020. WHO is the author of the listing. China is the manufacturing state. The listing enabled COVAX procurement.

The 31 December 2020 NMPA approval is a neighbouring earlier Chinese instrument.

The General Secretary of the Chinese Communist Party, concurrently President of the People’s Republic of China and Chairman of the Central Military Commission, can set the Politburo agenda, nominate the State Council leadership, and command the armed forces. He does not write UN General Assembly resolutions, OHCHR assessments, WHO emergency-use listings, or Hong Kong ordinances by himself.

## Evidence and sources

World Health Organization carries the official instrument or communique. Reuters records the same dated act independently.

## Significance

The path is [vaccine accessibility](/drivers/vaccine-accessibility): a completed WHO listing is a dated global-procurement ticket for a Chinese-made vaccine.

## What is established and what is not

Established: a 7 May 2021 WHO emergency-use listing of Sinopharm’s BBIBP-CorV.

Not established: a unique later African coverage rate from the listing hour, or that Xi sat on SAGE.

What would change the picture: a contradictory original with a different date or name, a later repeal, a court that vacated the instrument, or a measured series that can be argued, with lag and alternatives, as a consequence of this instrument rather than of later institutions.

The date is the date of this instrument, not a licence to back-date every later harm or benefit.

China manufactured it under an Xi-era state group. He did not sit as the SAGE panel.. A later repeal, court stay, or successor order would be a different Fact with a different date. That pair identifies WHO lists Sinopharm’s COVID-19 vaccine for emergency use, not a later speech about WHO lists Sinopharm’s COVID-19 vaccine for emergency use.

Co-authors and later implementers named in Context remain on the file. WHO lists Sinopharm’s COVID-19 vaccine for emergency use on 2021-05-07 is not a licence to treat every later World Health Organization communique as this same act. If a later repeal, stay, or successor decree exists, it needs its own date and its own row. This dossier refuses to average WHO lists Sinopharm’s COVID-19 vaccine for emergency use into a personality. The contribution described on this Person row is limited to Complex: WHO listed the vaccine. China manufactured it under an Xi-era state group. He did not sit as the SAGE panel. That limit is the alternative to treating office-holding as authorship of every later series. The National People’s Congress, the State Council, provincial governments, the People’s Liberation Army, Hong Kong’s executive, and foreign counterparties share specific files. Allegation is not a completed judgment. An OHCHR assessment is not a criminal conviction. A white paper is not a census. A UN pledge is not a delivered emissions path.

## People

- Xi Jinping: https://factrail.ai/people/xi-jinping

## Drivers

- Vaccine Accessibility: https://factrail.ai/drivers/vaccine-accessibility
- Public and donor investment in immunization systems: https://factrail.ai/drivers/ph-immunization-investment

## Sources

- https://www.reuters.com/business/healthcare-pharmaceuticals/who-gives-emergency-use-approval-chinas-sinopharm-covid-vaccine-2021-05-07/
- https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations

## Methodology

https://factrail.ai/methodology

Canonical: https://factrail.ai/facts/cn-who-eul-sinopharm-2021